We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Third-Party Payers’ Class Actions For Alzheimer’s Drugs Survive Dismissal

Mealey's (September 23, 2016, 10:19 AM EDT) -- NEW YORK — A New York federal judge on Sept. 13 left unscathed two third-party payer lawsuits alleging that the maker of the Alzheimer’s drug Namenda pulled their original version of...
To view the full article, register now.